A critical advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This vital cancer suppressor protein is frequently disabled in various forms of cancer, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research